News
Recruitment for the FAIR PARK II study is now closed: The last patient has been enrolled on December 5th 2019
The FAIR-PARK II 6h annual meeting was held virtually on 22nd April 2021
The FAIR-PARK II 5th annual meeting was held in Paris, France on 26th June 2019.
The FAIR-PARK II 4th annual meeting was held in Lisbon, Portugal on 15th and 16th June 2018.
The FAIR-PARK II 3rd annual meeting was held in Amsterdam, Netherlands on 26th and 27th June 2017.
The FAIR-PARK II 2nd annual meeting was held in Berlin, Germany on 23-24 June 2016.
The FAIR-PARK II kick-off meeting was held in Lille, France on 4-5 May 2015.
Recruitment for the FAIR PARK II study is now open: The first patient has been enrolled in Lille's hospital on February 9th 2016
The final list of European expert centres for the clinical trial is available since October 2015.
The final version of the protocol, as released by competent authorities and ethic national committees is available since january 2016
Patient Recruitment Countdown
16th December 2019
Patients to be recruited
0
Patients recruited
372
The recruitment is now closed
Nicola Pavese
Unew PI and WP3 Leader
Bart Post was born on March 30, 1972 in Grootebroek, the Netherlands. He obtained his medical degree in 1999 at the University of Maastricht (with honors). In 2000 he started his training as a resident in Neurology at the Academic Medical Centre in Amsterdam (head: prof. dr. M. Vermeulen), which he completed in December 2008. In 2002 he started a research project on ‘Prognosis in Parkinson’s disease’ that resulted in a PhD thesis in 2009. In 2006 he started a master of Sciences (MSc) education in clinical epidemiology at the EMGO institute in Amsterdam. In 2009 he was certified as a clinical epidemiologist. Since 2010 he works as a movement disorder neurologist in the Parkinson Centre in the Radboudumc in Nijmegen (head: prof. dr. B. Bloem). He is part of the steering committee of two large Parkinson trials in the Netherlands: the LEAP-trial (Early administration of levodopa in de novo PD); and the CHEVAL-trial (administration of acetylcholine inhibitors in PD patients with hallucinations). Furthermore he was an expert-rater at the EARLY-STIM trial (German-French trial on DBS early in the course of PD). At the department of neurology of the Radboudumc he is chair of the residency program for neurologists.
Jean Christophe Corvol
Jean-Christophe Corvol is Professor of Neurology at the Pitié-Salpêtrière, head of the Clinical Research Center for Neurosciences at the Institute of Brain and Spinal cord (ICM), co-Chair of the French clinical research network for Parkinson’s disease and Movement disorders (NS-Park). His field of interest is pharmacogenetics and gene modifiers in Parkinson’s disease.
Delphine Smagghe
Delphine joined Inserm Transfert in 2006 and leads the neurosciences group within the Collaborative Research Funding / European Affairs department. She holds a Master degree in chemical formulation and a post-Master degree in management of technological innovation in the bio-industries. Delphine has a strong track record of project management and proposal writing over the last 11 years. She also leads a process in the frame of the ISO 9001-2008 certification of the department, for the management of European and International biomedical research projects.
Dag Nyholm graduated as MD in 1999 and defended his PhD thesis 'Pharmacotherapy for Parkinson's disease - observations and innovations' at Uppsala University Hospital, Sweden, in 2003. Development of intestinal infusion of levodopa has been the major focus of research. He currently combines clinical work at the neurology clinic with research in movement disorders.
Form 1
Form 2
Form 3
Form 4
FAIR PARK II
Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone
Latest News Articles
Navigation
Contact Us
People
Scientific Coordinator: Prof David Devos
Project Manager (CHRUL): Pauline Guyon [email protected]
Senior Project Manager (IT): Delphine Smagghe [email protected]
Project Manager (IT): Stephanie Le Naour [email protected]
Addresses
Centre Hospitalier Regional et Universitaire de Lille (CHRUL), 2 avenue Oscar Lambret - 59037 Lille Cedex
Inserm-Transfert (IT), 7 rue de Watt - 75013 Paris, France
Lille CHRUL
Paris Inserm Transfert
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633190.
© FAIRPARK II 2015